Chronic Hepatitis in Dogs: Signs, Diagnosis and Care

The liver has remarkable compensatory capacity. Even when a substantial proportion of cells are damaged, the remaining healthy tissue can still maintain near-normal function. This is why many dogs with chronic hepatitis appear relatively well in the early and middle stages of the disease—and why the condition is so often discovered incidentally on blood tests during a routine exam rather than because the dog seems sick.

That compensatory reserve is limited. Once damage crosses a critical threshold, signs of liver failure—jaundice, fluid in the abdomen, neurological changes—can appear rapidly.

Causes and Dogs at Higher Risk

The causes of chronic hepatitis in dogs are varied, and identifying the specific cause is essential for choosing the right treatment.

Immune-mediated hepatitis is one of the most common forms. The immune system mistakenly attacks the liver's own cells, causing inflammation, cell death, and progressive fibrosis. The exact trigger is often unclear but may involve genetic predisposition, environmental factors, certain medications, or vaccination. Treatment typically requires immunosuppressive drugs.

Copper storage disease occurs when a genetic defect impairs the liver's ability to excrete copper through bile. Copper accumulates in liver cells over time, and once concentrations exceed a toxic threshold, it causes oxidative damage and inflammation. This form shows strong breed specificity.

Infectious causes include canine infectious hepatitis virus and Leptospira. While these usually present acutely, incomplete clearance of the pathogen can lead to chronic liver inflammation. With widespread vaccination, viral causes have become relatively uncommon.

Drug and toxin exposure is another potential trigger. Certain anticonvulsants, NSAIDs, and some antibiotics can produce cumulative liver damage with long-term use.

A significant proportion of cases are idiopathic—no specific cause is found despite thorough testing.

Any breed can develop chronic hepatitis, but several have significantly higher risk:

• Bedlington Terriers — the classic copper storage disease breed, with a well-characterized inherited copper metabolism defect. Responsible breeders use genetic testing to reduce transmission.
• West Highland White Terriers — also prone to copper accumulation, though the genetic mechanism may differ from Bedlington Terriers.
• Labrador Retrievers — studies indicate that the proportion of Labs with copper-related liver disease has increased in recent years. Female Labs appear to carry higher risk than males.
• Cocker Spaniels (English and American) — hepatitis in this breed may involve immune-mediated mechanisms, and disease progression can be relatively rapid.
• Doberman Pinschers — often related to both immune-mediated factors and copper accumulation, with higher incidence in females.
• Other breeds reported at elevated risk include Skye Terriers, Standard Poodles, and Dalmatians.

If your dog belongs to a high-risk breed, regular liver enzyme screening starting in adulthood is advisable.

Symptoms and Disease Progression

Chronic hepatitis is notoriously difficult to detect early because initial symptoms are vague and easily attributed to aging or minor digestive issues:

• Decreased appetite — becoming a picky eater or eating noticeably less.
• Gradual weight loss and declining energy.
• Intermittent vomiting or diarrhea.
• Increased thirst and urination.

These signs may wax and wane, creating a misleading pattern of apparent recovery followed by relapse.

As the disease progresses, more characteristic liver-specific signs appear:

• Jaundice — yellowing of the skin, gums, whites of the eyes, and inner ear flaps, caused by the liver's inability to properly process bilirubin.
• Ascites — fluid accumulation in the abdomen, producing visible distension. This results from decreased albumin production and increased portal vein pressure.
• Hepatic encephalopathy — when the liver can no longer clear toxins (especially ammonia) from the blood, neurological signs emerge: disorientation, aimless wandering, delayed responses, head pressing, and in severe cases seizures or coma.
• Bleeding tendency — gum bleeding, subcutaneous bruising, blood in stool or urine, resulting from impaired production of clotting factors.

How Chronic Hepatitis Is Diagnosed

Diagnosing chronic hepatitis requires a layered approach, starting with blood tests, progressing to imaging, and often concluding with a biopsy.

Blood biochemistry is the first-line screening tool. Key markers include:

• Liver enzymes (ALT, ALP) — persistent elevation or fluctuating increases suggest ongoing liver cell damage or biliary abnormalities.
• Albumin — low levels indicate reduced synthetic capacity.
• Bilirubin — elevated in jaundice.
• Ammonia — elevated when detoxification is impaired.
• Coagulation tests (PT, aPTT) — prolonged times reflect reduced clotting factor production.
• Complete blood count — checks for anemia or infection.

Abdominal ultrasound evaluates the liver's size, shape, and internal texture without invasive procedures. In chronic hepatitis, the liver may appear smaller than normal with irregular borders and heterogeneous echogenicity. Ultrasound also detects ascites, evaluates portal blood flow, and inspects the gallbladder and bile ducts. However, ultrasound alone cannot identify the specific type or cause of hepatitis.

Liver biopsy is the gold standard for chronic hepatitis diagnosis and the only reliable way to determine:

• The type and distribution of inflammation.
• The severity of fibrosis.
• Whether copper is accumulating (quantitative copper measurement).
• Whether the pattern suggests immune-mediated, toxic, infectious, or idiopathic disease.

Biopsy samples are typically collected using a fine needle or core biopsy needle under ultrasound guidance, or through laparoscopy. Although it is an invasive procedure, biopsy results are irreplaceable for choosing the right treatment and predicting prognosis.

Additional targeted tests may include serological screening for infectious agents, autoantibody panels for suspected immune-mediated disease, or genetic testing for hereditary copper storage disorders.

Treatment and Long-Term Monitoring

Treatment of chronic hepatitis must be individualized based on the specific cause and disease stage. The goals are to control inflammation, slow fibrosis, support liver function, and manage complications.

Immune-mediated chronic hepatitis is typically treated with:

• Corticosteroids (prednisone) as the first-line anti-inflammatory. Because long-term steroid use carries significant side effects, a second immunosuppressive agent—azathioprine or mycophenolate mofetil—is often added to allow lower steroid doses.
• Treatment usually continues for months and sometimes lifelong. Dose adjustments should always be guided by bloodwork and veterinary supervision.

Copper storage disease treatment focuses on:

• Dietary copper restriction — choosing low-copper foods and avoiding high-copper ingredients (liver, shellfish, certain grains).
• Copper chelators — penicillamine or trientine bind copper and promote urinary excretion.
• Zinc supplementation — reduces intestinal copper absorption.
• Progress is monitored through liver enzymes and, when necessary, repeat liver biopsy to measure copper levels.

Supportive care for all forms of chronic hepatitis may include:

• Antioxidants — vitamin E helps clear free radicals and reduce oxidative liver cell damage.
• Silymarin (milk thistle extract) — protects liver cell membranes and supports regeneration.
• Ursodeoxycholic acid — improves bile flow and reduces cholestatic damage.

Dietary management is critical. A liver-friendly diet provides high-quality, easily digestible protein without overloading the liver, moderate fat, and easily digestible carbohydrates. Frequent small meals reduce metabolic pressure. Dogs with ascites may need sodium restriction.

Complication management:

• Ascites — diuretics; severe cases may require abdominal paracentesis.
• Hepatic encephalopathy — lactulose to reduce ammonia absorption, dietary protein adjustment.
• Coagulation disorders — vitamin K supplementation or plasma transfusion when needed.

Regular follow-up ties everything together. Scheduled blood tests track liver enzymes, albumin, bilirubin, and clotting parameters. Periodic ultrasound monitors structural changes. At home, watch for shifts in appetite, energy, stool color, and abdominal size, and report changes to your vet promptly.

With early detection and consistent, cause-specific treatment, many dogs with chronic hepatitis maintain good quality of life for years.

This article is for informational purposes only and does not replace professional veterinary diagnosis or treatment. If your dog shows signs of liver disease, consult your veterinarian.

Sources

1. Canine Chronic Hepatitis — Merck Veterinary Manual
2. Disorders of the Liver and Gallbladder in Dogs — Merck Veterinary Manual
3. Copper Toxicosis in Animals — Merck Veterinary Manual